Immunoglobulin Structure and Function III Effector Mechanisms of Humoral Immunity Lecture 12 August 10, 2004 Lecturer: Wolcott Reading for Lectures 11-13: Kuby 5e, 87-104: 57-75: and 137-160 - PowerPoint PPT Presentation

About This Presentation
Title:

Immunoglobulin Structure and Function III Effector Mechanisms of Humoral Immunity Lecture 12 August 10, 2004 Lecturer: Wolcott Reading for Lectures 11-13: Kuby 5e, 87-104: 57-75: and 137-160

Description:

Title: Immunoglobulin Structure and Function III Effector Mechanisms of Humoral Immunity Lecture 12 August 10, 2004 Lecturer: Wolcott Reading for Lectures 11-13: Kuby ... – PowerPoint PPT presentation

Number of Views:219
Avg rating:3.0/5.0
Slides: 54
Provided by: inEmbnet
Learn more at: http://www.in.embnet.org
Category:

less

Transcript and Presenter's Notes

Title: Immunoglobulin Structure and Function III Effector Mechanisms of Humoral Immunity Lecture 12 August 10, 2004 Lecturer: Wolcott Reading for Lectures 11-13: Kuby 5e, 87-104: 57-75: and 137-160


1
Understanding Immune Recognition
2
Antigen Recognition
  • B cells can recognise antigens via their surface
    Ig molecules
  • T cells can only recognise antigen in association
    with a Major Histocompatibility Complex (MHC)
    molecule.

3
Antigen Recognition
  • B cells can recognise antigens via their surface
    Ig molecules
  • T cells can only recognise antigen in association
    with a Major Histocompatibility Complex (MHC)
    molecule.

4
The Immunoglobin Fold
5
Immunoglobin Fold
  • V and C domains share the basic Ig fold
  • Differences between the two domains
  • C domain is built of seven b-strands arranged so
    that four strands form one sheet and three
    strands form a second sheet.
  • The strands are closely packed together and
    joined by a single disulphide bond
  • Most of the invariant residues of the constant
    domain are in the sheets
  • Overall structure of the V domain very similar
    but there are nine strands instead of seven. The
    two additional strands harbour CDR2

6
Structure of antibody
7
Complementarity Determining Regions in Ig
8
The Complementarity Determining Regions
  • Six loops of the VH (H1, H2 and H3) and VL (L1,
    L2 and L3) domains create a great variety of
    surfaces
  • Deep binding cavities such as those seen in some
    antibody-hapten complexes
  • Wide pockets seen in certain antibody-peptide
    complexes
  • Flat surfaces seen in antibody-protein
    interactions
  • H3 is the most variable of the loops and in all
    crystallographically solved antibody-antigen
    complexes makes several contacts with antigen

9
What Do Antibodies Recognize?
  • Proteins (conformational determinants, denatured
    or proteolyzed determinants)
  • Nucleic acids
  • Polysaccharides
  • Some lipids
  • Small chemicals (haptens)

10
AntigenAntibody complex
  • Antibodies bind to antigens by recognizing a
    large surface, and through surface
    complementarity.
  • Thus, these complexes have a very high affinity
    for each other.

11
Weak forces vs high affinity
  • The interaction between an antigen and antibody
    can be very strong, and yet all of the forces
    involved are considered to be relatively weak.
    How can weak hydrogen bonds, electrostatic
    attractions, hydrophobic forces, and van der
    Waals contacts lead to a high affinity?
  • Contact between antigen and antibody occurs over
    a wide surface area, allowing multiple weak
    interactions that give a strong affinity
  • Hydrogen bonds join the antibody and antigen over
    a wide surface area. Other weak forces, including
    van der Waals forces, electrostatic attractions
    and hydrophobic forces, add to the strength and
    specificity of antibody/antigen binding

12
Antibody-Hapten Complex
  • Haptens, having a limited total surface area,
    deeply embed themselves into the VL/VH dimer
    interface
  • Hapten binding antibodies frequently show a deep
    central cavity, long CDR L1 loops and a CDR H3
    loop with an "open" conformation, allowing the
    hapten to bind as much as 80 of its total
    surface in the interaction.

13
Intimate interaction between Ab and Hapten
14
Peptide Antibody Complex
15
Protein Antibody Complex
  • In contrast, proteins preferentially to a
    relatively flat binding surface
  • In a "closed" CDR H3 conformation, the CDR H3
    loop packs down onto the central cavity, and the
    protein antigen binds on top of it.

16
Effector response is mediated via Ig-FcR complex
formation
  • Antibodies not only must recognize antigen, but
    also must invoke responses effector functions
    that will remove the antigen and kill the
    pathogen.
  • Variable regions of antibody are the sole agents
    of binding to antigen.
  • The heavy chain constant region (CH) is
    responsible for interactions with other proteins
    (e.g. complement), cells (elements of innate
    immune system), and tissues that result in the
    effector functions of the humoral response.
  • FcR recognize the Fc portion of antibodies not
    antigens

17
The Fc-Fc Receptor complex
  • FcR plays important role in antibody mediated
    immune responses
  • Ig and FcR binding activates effector functions
  • Fc Receptor interacts with the CH2 and CH3
    domains of Immunoglobulins

18
Mode of interaction of FcR with difference Ig
molecules
19
Immune Recognition MHC and TCR interactions
20
Antigen Recognition
  • B cells can recognise antigens via their surface
    Ig molecules
  • T cells can only recognise antigen in association
    with a Major Histocompatibility Complex (MHC)
    molecule.

21
T cells
  • T cells display TCR as their antigen recognition
    protein
  • When stimulated they become Cytotoxic or Helper T
    cells
  • Secrete cytokines that recruit other cells of the
    IS
  • TCRs only recognise short peptides.

22
MHC T cells
  • T cells have a requirement to recognise both the
    ANTIGEN and the MHC molecule. This is because
    the molecular structure of the MHC-Antigen
    complex is arranged so that some of the
    polymorphic amino acids of the MHC molecule are
    in direct contact with the TCR
  • Therefore T cell recognition of antigen is said
    to be MHC restricted.

23
Antigen Processing and Presentation
  • Fragmentation of protein into peptides
  • Association of peptide with an MHC molecule
  • Transport to cell surface for expression
  • Different cellular pathways for association of
    peptide with MHC class I and class II molecules

24
MHC Antigens
  • MHC Class I
  • present endogenously derived peptides.
  • these can be either self or derived from viruses
  • because MHC Class I is present on all cells any
    cell can interact with T cells if infected by a
    virus
  • MHC Class II
  • present exogenous antigen which has been
    phagocytosed and processed.eg. Bacteria
  • This is performed by professional antigen
    presenting cells eg macrophages

25
MHC
  • MHC Class II
  • seen only on the professional antigen processing
    cells e.g macrophage
  • slightly less polymorphic
  • accepts peptides of up to 15 aa acids
  • MHC Class I
  • detected on all nucleated cells
  • very highly polymorphic
  • Tight fit for peptides of only about 9 aa
  • consists of an a-chain of 3 domains associated
    with b-2 microglobulin

26
MOLECULES OF T LYMPHOCYTE RECOGNITION
  • Major histocompatibility complex (MHC)
    humanHuman Leukocyte Antigen (HLA) mouseH-2
  • Gorer and Snell identified a genetic basis for
    graft rejection and Snell named it
    histocompatibility 2 (H-2). Nobel prize awarded
    to Snell.
  • Highly polymorphic genes organized in a complex
    on chromosome 6 (human) and 17 (mouse).
  • Glycoproteins expressed on the surface of cells.
    MHC class I is composed of one polypeptide,
    non-covalently associated with b2microglobulin.
    MHC class II is composed of two polypeptides,
    referred to as a and b.

27
MHC Class I and Class II Proteins
  • Class I
  • Alpha Chain
  • 3 External domains
  • 1 Transmembrane
  • 1 Cytoplasmic tail
  • Encoded in MHC
  • Beta-2 Microglobulin
  • 1 External domain
  • No transmembrane
  • No Cytoplasmic tail
  • Not encoded in MHC
  • Class II
  • Alpha Chain
  • 2 External domains
  • 1 Transmembrane
  • 1 Cytoplasmic Tail
  • Encoded in MHC
  • Beta Chain
  • 2 External domains
  • 1 Transmembrane
  • 1 Cytoplasmic Tail
  • Encoded in MHC

28
MHC Class I and Class II Proteins
29
Peptides bind to MHC molecules in a polyproline
II conformation
30
Class IPeptide Binding
31
MHC-II Structure
32
Peptide Binding by Major Histocompatibility
Complex (MHC) Antigen-presenting Proteins
MHC I
MHC II
  • Peptides of intracellular origin
  • Peptides 9-10 residues long
  • Deep pockets bind peptide sidechains
  • Deep pockets bind peptide N- and C-termini
  • Peptides of extracellular origin
  • Peptides 15 residues or longer
  • Shallow pockets bind peptide sidechains
  • Peptide termini free
  • H-bonds to peptide backbone

33
(No Transcript)
34
MHC Polymorphism
  • Both Class I and Class II genes are highly
    polymorphic
  • Most polymorphic residues of Class I are in the
    alpha 1 and alpha 2 domains
  • Most polymorphic residues of Class II are in the
    alpha 1 and beta 1 domains

35
Location of Polymorphic Residues
36
Location of Polymorphic Residues
37
Allelic variation in MHC occurs at the peptide
binding site and on the top/sides of the binding
cleft
38
(No Transcript)
39
T-cell Receptor
40
The T cell receptor (TCR) is a complex of
integral membrane proteins that participates in
the activation of T cells in response to the
presentation of antigen. Specific recognition
and binding by the clonotype-specific a/b
heterodimer leads to activation of transcription
and commitment of the T cell to CD4 or CD8
fate. This activation involves other subunits of
the receptor complex as well as other
membrane-associated molecules that couple the
extracellular liganding event to downstream
signaling pathways such as protein
phosphorylation, the release of inositol
phosphates and the elevation of intracellular
calcium levels.
41
(No Transcript)
42
(No Transcript)
43
(No Transcript)
44
TCR binds peptide/MHC with a restricted (but
variable) orientation
45
peptide binding interface 21-34 proportion of
TCR contacts with the peptide26-47 contact are
different between TCR-MHC complex -the
contribution to the binding energy is still
uncleared!
Bandovich and Garcia. 2003. Immunity 18,7-11
46
(No Transcript)
47
TRI-MOLECULAR COMPLEX CHARACTERISTICS
-CDR1 and CDR2 interact with MHC molecules (a
helices)
-CDR3 interacts with the peptide
-interaction always in the same orientation -45
to 70 degrees angle related to peptide -Va see
N-ter of the peptide -Vb see C-ter of the peptide
48
TRI-MOLECULAR COMPLEX CHARACTERISTICS
- most of the binding interface is between the
TCR and MHC helices - conformational change
in the TCR CDR loops enhances TCR
crossreactivity - no conformational change in
the TCR constant region (except in one complex
out of ten)
49
(No Transcript)
50
(No Transcript)
51
Recognition of the Super Antigens
52
Antigen Recognition by Antibodies (Ab) and T-cell
Receptors (TCR)
Ab - Ag
TCR MHC/peptide
  • Surface area 2x750 Å2
  • Epitope discontinuous in antigen (Ag) sequence
  • Surface area 2x1000 Å2
  • Ag peptide contributes only 40 of surface area
  • Epitope continuous in Ag sequence
  • Otherwise similar to Ab - Ag recognition

53
PARADOX
-TCR-MHC interaction has a weak
affinity -affinity 10 mM -half-life 10s
-restricted numbers of ligands (100) are
displayed at the surface of antigen presenting
cells
-T cell activation requires a long interaction
with antigen presenting cells (gt2h)
Write a Comment
User Comments (0)
About PowerShow.com